-+ 0.00%
-+ 0.00%
-+ 0.00%

ARVINAS: FINDINGS SUPPORT EVALUATION OF ARV-102 AS A THERAPEUTIC APPROACH FOR NEURODEGENERATIVE DISEASES ASSOCIATED WITH LRRK2 DYSREGULATION

Reuters·10/07/2026 11:07:06